16 March 2026
16 March 2026
While the FDA maintains the legal right to make prescription meds OTC, legal expert Heidi Gertner believes that this wider shift depends on pharma’s engagement.
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA in this expanded, high-risk adult population.
Cosentyx’s IL-17A mechanism provides a differentiated approach for HS in younger patients.
The collaboration builds on Biophytis' ongoing partnership with LynxKite and aligns with Singapore’s research, innovation and enterprise (RIE) 2030 plan.
WHO’s director of antimicrobial resistance, Dr Yvan Hutin, says science needs to catch up with drug-resistant bacteria.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
